{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T22:59:01Z","timestamp":1715986741877},"reference-count":18,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostic Microbiology and Infectious Disease"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1016\/j.diagmicrobio.2010.09.017","type":"journal-article","created":{"date-parts":[[2011,2,25]],"date-time":"2011-02-25T09:40:17Z","timestamp":1298626817000},"page":"275-279","source":"Crossref","is-referenced-by-count":9,"title":["In vitro activity of telavancin and comparator antimicrobial agents against a panel of genetically defined staphylococci"],"prefix":"10.1016","volume":"69","author":[{"given":"David J.","family":"Farrell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin M.","family":"Krause","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bret M.","family":"Benton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.diagmicrobio.2010.09.017_bb0005","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1128\/JCM.36.8.2187-2190.1998","article-title":"Emergence of vancomycin-resistant enterococci in Australia: phenotypic and genotypic characteristics of isolates","volume":"36","author":"Bell","year":"1998","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.diagmicrobio.2010.09.017_bb0010","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1128\/AAC.46.3.880-882.2002","article-title":"High prevalence of oxacillin-resistant Staphylococcus aureus isolates from hospitalized patients in Asia-Pacific and South Africa: results from SENTRY antimicrobial surveillance program, 1998\u20131999","volume":"46","author":"Bell","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.diagmicrobio.2010.09.017_bb0015","series-title":"M7-A7: Methods for dilution of Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically; Approved standard - Seventh edition","author":"CLSI","year":"2006"},{"issue":"Suppl 1","key":"10.1016\/j.diagmicrobio.2010.09.017_bb0020","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1086\/491711","article-title":"Vancomycin resistance in gram-positive cocci","volume":"42","author":"Courvalin","year":"2006","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2010.09.017_bb0025","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1128\/AAC.01641-07","article-title":"Comparative surveillance study of telavancin activity against recently collected gram-positive clinical isolates from across the United States","volume":"52","author":"Draghi","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.diagmicrobio.2010.09.017_bb0030","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1093\/jac\/dkn124","article-title":"In vitro activity of telavancin against recent Gram-positive clinical isolates: results of the 2004\u201305 Prospective European Surveillance Initiative","volume":"62","author":"Draghi","year":"2008","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.diagmicrobio.2010.09.017_bb0035","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1086\/427148","article-title":"Severe community-onset pneumonia in healthy adults caused by methicillin-resistant Staphylococcus aureus carrying the Panton\u2013Valentine leukocidin genes","volume":"40","author":"Francis","year":"2005","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2010.09.017_bb0040","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.1128\/AAC.48.8.3043-3050.2004","article-title":"Pharmacodynamics of telavancin (TD-6424), a novel bactericidal agent, against gram-positive bacteria","volume":"48","author":"Hegde","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.diagmicrobio.2010.09.017_bb0045","doi-asserted-by":"crossref","first-page":"2647","DOI":"10.1128\/AAC.01398-07","article-title":"In vitro activity of telavancin against resistant gram-positive bacteria","volume":"52","author":"Krause","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.diagmicrobio.2010.09.017_bb0050","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00301-10","article-title":"In vitro activity evaluation of telavancin against a contemporary worldwide collection of Staphylococcus aureus","author":"Mendes","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.diagmicrobio.2010.09.017_bb0055","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.ajic.2004.10.001","article-title":"National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004","volume":"32","author":"National Nosocomial Infections Surveillance System","year":"2004","journal-title":"Am. J. Infect. Control"},{"key":"10.1016\/j.diagmicrobio.2010.09.017_bb0060","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1128\/AAC.46.7.2155-2161.2002","article-title":"Multiplex PCR strategy for rapid identification of structural types and variants of the mec element in methicillin-resistant Staphylococcus aureus","volume":"46","author":"Oliveira","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.diagmicrobio.2010.09.017_bb0065","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1093\/jac\/dkl222","article-title":"Efficacy of telavancin in a murine model of bacteraemia induced by methicillin-resistant Staphylococcus aureus","volume":"58","author":"Reyes","year":"2006","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.diagmicrobio.2010.09.017_bb0070","doi-asserted-by":"crossref","first-page":"4344","DOI":"10.1128\/AAC.49.10.4344-4346.2005","article-title":"Efficacy of telavancin (TD-6424), a rapidly bactericidal lipoglycopeptide with multiple mechanisms of action, in a murine model of pneumonia induced by methicillin-resistant Staphylococcus aureus","volume":"49","author":"Reyes","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.diagmicrobio.2010.09.017_bb0075","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1086\/420937","article-title":"Trends in antimicrobial drug development: implications for the future","volume":"38","author":"Spellberg","year":"2004","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2010.09.017_bb0080","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1128\/AAC.40.11.2562","article-title":"Detection of erythromycin-resistant determinants by PCR","volume":"40","author":"Sutcliffe","year":"1996","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.diagmicrobio.2010.09.017_bb0085","doi-asserted-by":"crossref","first-page":"34","DOI":"10.2807\/esm.05.03.00024-en","article-title":"European Antimicrobial Resistance Surveillance System (EARSS): susceptibility testing of invasive Staphylococcus aureus","volume":"5","author":"Veldhuijzen","year":"2000","journal-title":"Eur. Surveill."},{"key":"10.1016\/j.diagmicrobio.2010.09.017_bb0090","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1093\/jac\/dkg104","article-title":"Linezolid resistance in clinical isolates of Staphylococcus aureus","volume":"51","author":"Wilson","year":"2003","journal-title":"J. Antimicrob. Chemother."}],"container-title":["Diagnostic Microbiology and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889310004311?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889310004311?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,16]],"date-time":"2020-06-16T22:56:41Z","timestamp":1592348201000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0732889310004311"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3]]},"references-count":18,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["S0732889310004311"],"URL":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2010.09.017","relation":{},"ISSN":["0732-8893"],"issn-type":[{"value":"0732-8893","type":"print"}],"subject":[],"published":{"date-parts":[[2011,3]]}}}